Abstract
The therapy for tension-type headache remains insufficient, and recent advances have been scarce. Although tricyclic antidepressants are at the forefront of treatment advances, upcoming agents tentatively modifying central sensitization are promising. Botulinum toxin failed to meet expectations. This article reviews current treatments, emphasizing newer approaches. Much remains to be achieved.
Similar content being viewed by others
References and Recommended Reading
Zhao C, Stillman M: New developments in the pharmacotherapy of tension-type headache. Expert Opin Pharmacother 2003, 4:2229–2237.
Cassidy EM, Tomkins E, Hardiman O, O’Keane V: Factors associated with burden of primary headache in a specialty clinic. Headache 2003, 43:638–644.
Couch JR: The long-term prognosis of tension-type headache. Curr Pain Headache Rep 2005, 9:436–441.
Blau JN: Sleep-deprivation headache. Cephalalgia 1990, 10:157–160.
Silberstein SD, Winner PK, Chmiel JJ: Migraine preventive medication reduces resource utilization. Headache 2003, 43:171–178.
Packman B, Packman E, Doyle G, et al.: Solubilized ibuprofen: evaluation of onset, relief and safety of a novel formulation in the treatment of episodic tension-type headache. Headache 2000, 40:561–567.
Martinez-Martin P, Raffaelli E Jr, Titus F, et al.: The Co-operative Study Group. Efficacy and safety of metamizole versus acetylsalicylic acid in patients with moderate episodic tension-type headache: a randomized, double-blind, placebo-and active-controlled, multicenter study. Cephalalgia 2001, 21:604–610.
Bigal ME, Bordini CA, Speciali JG: Intravenous metamizole in acute migraine treatment and in episodic tension-type headache; a placebo-controlled study. Cephalalgia 2001, 21:90–95.
Farinelli I, Martelletti P: Aspirin and tension-type headache. J Headache Pain 2007, 8:49–55.
Lenaerts M, Couch JR: Medication overuse headache. Minerva Med 2007, 98:221–231.
Katsarava Z, Muessig M, Dzagnidze A, et al.: Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia 2005, 25:12–15.
Lance JW, Curran DA: Treatment of tension-type headache. Lancet 1964, 1:1236–1239.
Bendtsen L, Jensen R: Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headache. Cephalalgia 2000, 20:603–610.
Boz C, Altunayoglu V, Velioglu S, Ozmenoglu M: Sertraline versus amitriptyline in the prophylactic therapy of non-depressed chronic tension-type headache patients. Headache 2002, 4:72–78.
Cerbo R, Barbaranti P, Fabbrini G, et al.: Amitriptyline is effective in chronic but not episodic tension-type headache: pathogenetic implications. Headache 1998, 38:453–457.
Pfaffenrath V, Diener HC, Isler H: Efficacy and tolerability of amitriptilinoxide in the treatment of chronic tension-type headache: a multi-center controlled study. Cephalalgia 1994, 14:149–155.
Mathew NT: Prophylaxis of migraine and mixed headache. A randomized controlled trial. Headache 1981, 21:105–109.
Tomkins GE, Jackson JL, O’Malley PG, et al.: Treatment of chronic headache with antidepressant: a meta-analysis. Am J Med 2001, 111:54–63.
Bendtsen L, Jensen R, Olesen J: A non-selective (amitriptyline) but not a selective (citalopram) serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry 1996, 61:285–290.
Cohen GL: Protriptyline, tension-type headaches and weight loss in women. Headache 1997, 37:433–436.
Langemark M, Loldrup D, Bech P, Olesen J: Clomipramine and mianserin in the treatment of chronic tension-type headache: a double-blind, controlled study. Headache 1990, 30:118–121.
Bettucci D, Testa L, Calzoni S, et al.: Combination of tizanidine and amitriptyline in the prophylaxis of chronic tension-type headache: evaluation of efficacy and impact on quality of life. J Headache Pain 2006, 7:34–36.
Couch JR, Ziegler DK, Hassanein R: Amitriptyline in the prophylaxis of migraine. Effectiveness and relationship of antimigraine and antidepressant effects. Neurology 1976, 26:121–127.
Ashina S, Bendtsen L, Jensen R: Analgesic effect of amitriptyline in chronic tension-type headache is not directly related to serotonin reuptake inhibition. Pain 2004, 108:108–114.
Holroyd KA, Labus JS, O’Donnell FJ, Cordingly GE: Treating chronic tension-type headache not responding to amitriptyline hydrochloride with paroxetine hydrochloride: a pilot evaluation. Headache 2003, 43:999–1004.
Singh NN, Misra S: Sertraline in chronic tension-type headache. J Assoc Phys India 2002, 50:873–878.
Adelman LC, Adelman JU, Von Seggern R, Mannix LK: Venlafaxine extended-release (XR) for the prophylaxis of migraine and tension-type headache: a retrospective study in a clinical setting. Headache 2000, 40:572–580.
Manna V, Bolino F, Di Cicco L: Chronic tension-type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserin. Headache 1994, 34:44–49.
Bendtsen L, Jensen R: Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 2004, 62:1706–1711.
Bendtsen L, Buchgreitz L, Ashina S, Jensen R: Combination of low-dose mirtazapine and ibuprofen for prophylaxis of chronic tension-type headache. Eur J Neurol 2007, 14:187–193.
Miner JR, Smith SW, Moore J, Biros M: Sumatriptan for the treatment of undifferentiated primary headaches in the ED. Am J Emerg Med 2007, 25:60–64.
Brennum J, Brinck T, Schriver L, et al.: Sumatriptan has no clinically relevant effect in the treatment of episodic tension-type headache. Eur J Neurol 1996, 3:23–28.
Lenaerts M, Bastings E, Sianard-Gainko J, Schoenen J: Sodium valproate in severe migraine and tension-type headache patients: an open study of long-term efficacy and correlation with blood levels. Acta Neurol Belg 1996, 96:126–129.
Lampl C, Marecek S, May A, Bendtsen L: A prospective, open-label, long-term study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache. Cephalalgia 2006, 26:1203–1208.
Ashina M, Lassen LH, Bendtsen L, et al.: Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomized, controlled trial. Lancet 1999, 353:287–289.
Ashina M: Nitric oxide synthase inhibitors for the treatment of tension-type headache. Expert Opin Pharmacother 2002, 3:395–399.
Ashina S, Ashina M: Current and potential future drug therapies for tension-type headache. Curr Pain Headache Rep 2003, 7:466–474.
Altura BM, Altura BT: Tension headaches and muscle tension: is there a role for magnesium? Med Hypotheses 2001, 57:705–713.
Lenaerts M, Sianard-Gainko J, Schoenen J: Blood magnesium levels in migraine. Cephalalgia 1991, 11:97–99.
Mauskop A, Altura BT, Cracco RQ, Altura BM: Intravenous magnesium sulfate rapidly alleviates headaches of various types. Headache 1996, 36:154–160.
Farinelli I, Coloprisco G, De Filippis S, Martelletti P: Long-term benefits of botulinum toxin type A (BOTOX) in chronic daily headache: a five-year long experience. J Headache Pain 2006, 7:407–412.
Anderson RE, Seniscal C: A comparison of selected osteopathic treatment with relaxation for tension-type headache. Headache 2006, 46:1273–1280.
Torelli P, Jensen R, Olesen J: Physiotherapy for tension-type headache: a controlled study. Cephalalgia 2004, 24:29–36.
van Ettekoven H, Lucas C: Efficacy of physiotherapy including a craniocervical training programme for tension-type headache; a randomized clinical trial. Cephalalgia 2006, 26:983–991.
Leinisch-Dahlke E, Jurgens T, Bogdahn U, et al.: Greater occipital nerve block is ineffective in chronic tension type headache. Cephalalgia 2005, 25:704–708.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lenaerts, M.E. Future therapeutic perspectives for tension-type headache. Current Science Inc 11, 461–464 (2007). https://doi.org/10.1007/s11916-007-0234-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11916-007-0234-0